Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,074 public trials 3,988 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

NCT04628026

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Tirol Kliniken GmbH Innsbruck, Austria
  • Kepler Universitaetsklinikum GmbH Linz, Austria
  • Ordensklinikum Linz GmbH Linz, Austria
  • Landeskrankenhaus (LKH) Rankweil, Interne E am Landeskrankenhaus Rankweil Rankweil, Austria
View all 91 locations
View Trial Details
Recruiting

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

NCT06948318

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC Los Angeles, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Georgetown University Medical Center - Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
View all 118 locations
View Trial Details
Recruiting

A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)

NCT06561360

Conditions
Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
View Trial Details
Recruiting

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

NCT06854653

Conditions
CTCL, Disease Attributes, Hemic and Lymphatic Diseases, +15 more
Locations
  • City of Hope Comprehensive Cancer Cente Duarte, California, United States
  • University of California Irvine Irvine, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 15 locations
View Trial Details

Related conditions